龙舟竞渡与祭祀屈原
網站地圖 聯系我們搜索內部網English | 中國科學院
首頁 所況簡介 機構設置 科研隊伍 科學研究平臺 院地合作 黨群園地 國際交流 博士后 研究生教育 信息公開
科研進展
成果報道
最新重要論文(影響因子PNAS及以上)
發表論文數據庫
所級學術報告
科學成果
發表論文
專著
專利
獲獎
專題
所史叢書
所慶專輯
建所50周年畫冊
現在位置:首頁 > 科研進展 > 最新重要論文(影響因子PNAS及以上)
Fenozyme Protects the Integrity of Blood Brain Barrier against Experimental Cerebral Malaria, Nano letters, 01 Nov 2019
2019-11-01 | 【     】【打印】【關閉

Nano letters01 November, 2019,DOI:https://doi.org/10.1021/acs.nanolett.9b03774

Fenozyme Protects the Integrity of Blood Brain Barrier against Experimental Cerebral Malaria

Shuai Zhao, Hongxia Duan, Yili Yang, Xiyun Yan and Kelong Fan

Abstract

Cerebral malaria is a lethal complication of malaria infection characterized by central nervous system dysfunction, and is often not effectively treated by the anti-malaria combination therapies. It has been shown that the sequestration of the parasite infected red blood cells that interact with cerebral vessel endothelial cells and the damage of the blood-brain barrier (BBB) play critical roles in the pathogenesis. In this study, we developed a ferritin nanozyme (Fenozyme) composed of recombinant human ferritin (HFn) protein shells that specifically target to BBB endothelial cells (BBB ECs), and inner Fe3O4 nanozyme core that exhibits reactive oxygen species-scavenging catalase-like activity. In the experimental cerebral malaria (ECM) mouse model, administration of the Fenozyme, but not HFn, markedly ameliorated the damage of BBB induced by the parasite and improved the survival rate of infected mice significantly. Further investigations found that Fenozyme, as well as HFn, was able to polarize the macrophages in liver to M1 phenotype and promote the elimination of malaria in the blood. Thus, the catalase-like activity of the Fenozyme is required for its therapeutic effect in the mouse model. Moreover, the Fenozyme significantly alleviated the brain inflammation and memory impairment in ECM mice that had been treated with artemether, indicating that combining Fenozyme with anti-malaria drug is a novel strategy for the treatment of cerebral malaria.

文章鏈接:https://pubs.acs.org/doi/10.1021/acs.nanolett.9b03774

相關報道:http://www.zwfnu.club/kyjz/zxdt/201911/t20191104_5420434.html

 

 

評 論
           
版權所有:中國科學院生物物理研究所     京ICP備05002792號 京公網安備 110402500011 號
地址:北京市朝陽區大屯路15號(100101) 電話:010-64889872
意見反饋聯系人:侯文茹 電子郵件:[email protected]
龙舟竞渡与祭祀屈原 861901641349174469126683956715303428146251544027097183479672536552145470980341445013132871949894641 (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = 'https://zz.bdstatic.com/linksubmit/push.js'; } else { bp.src = 'http://push.zhanzhang.baidu.com/push.js'; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();